Articles and insights
- Content hub
The latest reports, editorial and thought leadership from our experts.
More to explore
- Sustainable marketing
- Media Advisory Panel
9th June 2025: The PM (Pharmaceutical Marketing) Society is delighted to announce a new partnership with the CIM (Chartered Institute of Marketing) to build capability and excellence in marketing in the pharmaceutical industry.
The partnership, called the PMS & CIM Marketing Leaders Programme, will centre around a series of three-days face to face development training at CIM’s headquarters in October, delivered by two senior CIM course directors and focused around developing strategic marketing skills and personal brand.
The PM Society is funding this initiative which is part of the Marketing Excellence Industry Group, co-chaired by Simon Grime and Ed Thesiger.
Applications to take part will be sought from senior marketing/brand managers in pharmaceutical companies who meet the CIM qualifying criteria. The three days will be spread across two weeks in October and will be open to 10 candidates.
Once completed, three exceptional candidates who meet the criteria will be chosen to be awarded the prestigious CIM Fellowships, which will be presented by Chris Daly, Chief Executive of CIM on stage at the PM Society’s flagship event, the 2026 PM Awards in March.
Commenting on the partnership, Simon Grime, Partner at the PM Society said: "This is a very exciting partnership that we’re proud to have entered into. It aims to really help promote progress in marketing in pharma for those who have been in the industry already for several years and want to expand their remit at a more senior level."
Chris Daly, FCIM, CEO at the CIM, commented: "We’re excited about this partnership with the PM Society as the pharmaceutical industry is an important sector that we work with regularly. This programme will further embed the value of developing high level capability and performance."
The aims of the PM Society Marketing Excellence Industry Group are:
-ENDS-
For PM Society media enquiries
Carwyn Jones
Director
carwynjones@pmsociety.org.uk
For CIM media enquiries
James Delves
Head of PR, Content and Community, CIM
James.Delves@cim.co.uk
About The PM (Pharmaceutical Marketing) Society
The PM Society is a not-for-profit organisation, which was founded over 40 years ago. Today it has over 4000 active members from over 250 companies and has three aims – to support organisations and people in healthcare, to recognise excellence and promote best practice and to provide education and training. For more information see our website at www.pmsociety.org.uk.
About CIM
For over 100 years, CIM has been the universal voice of marketing, championing our industry and its positive impact on organisations, economies and the wider society. Today, we play a more significant role than ever in supporting, developing and representing our members and the profession around the world. Always on top of the latest developments, we offer inspiring insights and thought leadership to generate transformative discussion and ideas.
On an individual level, marketers at every stage of their career find us a trusted and people-centred provider of clear guidance, training and professional qualifications – especially on their path to being accredited as a Chartered Marketer. If it carries a CIM stamp, it’s taken seriously: proof of the essential skills that boost long-term success for any business.
We’re at the forefront of all that’s exciting about marketing. Our services build careers and boost businesses. We continue to speak out for our industry, working alongside like-minded organisations to bring on the latest generations of talent and set professional standards for the entire marketing ecosystem. Find out more about CIM by visiting www.cim.co.uk.
An overview of CIM our history and services.
We’ll always treat your personal details with the utmost care and will never share or sell them to third parties. You are always in control of how we contact you – you can change your contact preferences at any time. For more information, visit our privacy policy.
To receive sector specific news: